In a more relevant tumor model, we showed that HB-19 treatment for several months delays significantly the onset and frequency of spontaneous melanoma in RET mice, impairs tumor angiogenesis, and reduces metastasis while displaying no toxicity to normal tissue [38]. This evidence concerns the gene RET and melanoma.